|
¤@¡B¶D³^®×¥ó·§z
BioTechnology¤½¥q©ó2009¦~8¤ë28¤é¦VªF»«¦{Áp¨¹¦a¤èªk°|¡A´£°_¹ïCiba Vision¤½¥q±M§Q«IÅv¡A¥H¤ÎDrexel¤j¾Ç¥¼¼i¦æ¦X¬ùªº¶D³^¡C°_¶D®Ñ¤¤«ü¥XCiba Vision¤½¥q«I®` US5,080,924¡BUS5,260,093¡BUS5,326,584»PUS5,578,079µ¥¥|¥ó±M§Q¡A¦Ó³o¨Ç±M§Q¬O¥ÑDrexel¤j¾Ç»POphthalmic Research Corporation(ORC)¦@¦P¾Ö¦³(Joint Ownership)ªº¡C¨Ã©ó¶Dª¬¤¤¡A«ü¥X³Q§i¼t°Ó¬ÛÃö¤§«IÅv²£«~¸ê°T(°Ñ¨£www.us.cibavision.com)¡C
¥»¦¸¶D³^¯S¦â¤§¤@¬°Drexel¤j¾Ç¤@¤è±¬°«D¦ÛÄ@©Êì§i(Involuntary Plaintiff)¡A¦P®É¤]¬O³Q§i(Defendant)¡A¦]¬°»PBioTechnology¦@¦³¨tª§±M§Q©Ò¦³Åv¤§¬G¡C
ªí¤@¡B±M§Q¶D³^®×¥ó°ò¥»¸ê®Æ·J¾ã
´£§i¤é´Á |
2009¦~8¤ë28¤é |
ì§i |
BioTechnology, LLC |
³Q§i |
CibaVisionCorporation
DrexelUniversity |
¦aÂI |
United States District Court ¡VFor the Eastern District ofPennsylvania
ªF»«¦{Áp¨¹¦a¤èªk°|
|
®×¸¹ |
2:09-cv-03947-BMS |
¨tª§±M§Q |
US5,080,924 (Method of Making Biocompatible, Surface Modified Materials)
US5,260,093 (Method of Making Biocompatible, Surface Modified Materials)
US5,326,584 (Biocompatible, Surface Modified Materials of Making the same)
US5,578,079 (Biocompatible, Surface Modified Materials)
|
¸ê®Æ¨Ó·½¡G ¾G·ß¶W¡A¬ì§Þ¬Fµ¦¬ã¨s»P¸ê°T¤¤¤ß¡X¬ì§Þ²£·~¸ê°T«Ç¾ã²z¡A2009/09
ªí¤G¡B¨tª§±M§Q
| Publication |
Title |
Assignee |
Pub. Date |
Filed |
Priority |
IPC Code |
| US5080924 |
Method of making biocompatible, surface modified materials |
Drexel University |
1992-01-14 |
1989-04-24 |
1989-04-24 |
A61L 27/34 |
| US5260093 |
Method of making biocompatible, surface modified materials |
Drexel University |
1993-11-09 |
1992-01-13 |
1989-04-24 |
A61F 2/16 |
| US5326584 |
Biocompatible, surface modified materials and method of making the same |
Drexel University |
1994-07-05 |
1992-11-18 |
1989-04-24 |
A61F 2/16 |
| US5578079 |
Biocompatible, surface modified materials |
Drexel University |
1996-11-26 |
1993-04-14 |
1989-04-24 |
A61F 2/16 |
¤G¡B¨tª§±M§Q©Ò¦³Åvª¬ªp¸ÑªR
±M§Q¦@¦³ªº±¡ªp¤U¡A¥²¶·©Ò¦³±M§Q¦@¦³¤H¦@¦P°Ñ»P¶D³^¡A¥H§K¤@Ó«IÅv¦æ¬°¤Þµo¨âÓ¥H¤W¬Û¦P¤º®eªº¶D³^¡C¦b¤í¯Ê¥þ³¡¦@¦³¤H°Ñ¥[¶D³^ªº±¡ªp¤U¡A±MÄݳQ±ÂÅv¤H(Exclusive Licensee)©Î³¡¤Àªº±M§Q¦@¦P«ù¦³¤H(¦pORC)¡AµLªk³æ¿W¦¨¬°ì§i¡Aì«h¤W¥²¶·¦@¦³±M§QÅv¤Hªº°Ñ¥[¡A©l¦³¹ï«IÅv¤H´£°_¶D³^¤§·í¨Æ¤H¾A®æ¡C¹ï©ó¥¼°Ñ¥[¶D³^ªº±M§Q¦@¦³¤H¡A¥²¶·¨ú±o¨ä¤¹³\¡A©Î¬O±N¨ä¦C¬°«D¦ÛÄ@©Êì§i(Involuntary Plaintiff)¡A¥H²Å¦X¶D³^·í¨Æ¤H¾A®æ¤§n¥ó¡C
Drexel¤j¾Ç¦P®É¨³B³Q§i»Pì§i¤§Âù«¨¤À¡A«Y¦]¬°¦¹¦¸¶D³^¤§4¥ó¨tª§±M§Q¬Ò¬°Drexel»PBioTechnology¦@¦P¾Ö¦³¡C®Ú¾Ú¸Ó®Õ»PORC(¨ä«á³QBioTechnology¨ÖÁÊ)©ó1984¦~©Òñq¤§¦@¦P¬ã¨s¤è®×¨óij(Joint Research Program Agreement)«ü¥X¡A©Ò¦³¬ÛÃöªºµo©ú¡A¬Ò¥ÑDrexel»PORC©Ò¦@¦P¾Ö¦³¡AÂù¤è¨ã¦³¬Ûµ¥(Equal)¡B¤£¥i¤À³Î(Undivided)¡A¥H¤Î¦U¥bªº§Q¯q(One-half Interests)¡C¦X¬ù¤¤¶i¤@¨B©w¸q¡uµo©ú¡vªº½d³ò¡G¥]§t¥ô¦óµo©ú¡Bµo²{¡B§ï¶i¡AµL½×¬O§_¥i±M§Q©Ê(Patentable)¬ÒÄݤ§¡C¸Ó¨óij¹ï©ó±M§Q¥Ó½Ð¹Lµ{¥H¤Î¥¼¨Ó¥i¯àµo¥Í¶D³^®É¡ADrexel¥²¶·¥R¤À°t¦XORCªº¬ÛÃön¨D(to corporate fully with ORC)¡C
¦ý¬O¦b¶i¦æ¦h¦¸½R°Ó¤§«á¡AÂù¤è¤´µLªk¹F¦¨¨óij¡CBioTechnology©ó´£°_¶D³^®É¤@¨Ö±NDrexel¦C¬°³Q§i¡A±±§i¸Ó¤j¾Ç¥¼¼i¦æ¦X¬ù¤§¸q°È¡C
ªí¤T¡B±M§Q©Ò¦³Åvµo®i¨Æ¥óªí
¤é´Á |
¨Æ¥ó |
1984.3.5 |
Drexel»PORCñq¦@¦P¬ã¨s¤è®×¨óij(Joint Research Program Agreement) |
2004.3.16 |
ORC³QBio-Cellular, LLC ¨ÖÁÊ |
2008.12.17 |
Bio-Cellular±NORC©Ò¾Ö¦³ªº±M§Q²¾Â൹BioTechnology¡]¥]¬A»PDrexel¦@¦³¤§±M§Q¡^ |
2009.6.10 |
Bio-Cellular³QBioTechnology¨ÖÁÊ |
2009.5.19~ 2009.7.6
|
Drexel»PBioTechnologyÂù¤è«ß®v¦h¦¸¹ï©ó¦VCiba Vision¤½¥q´£°_¶D³^¶i¦æ¨ó°Ó¡An¨DDrexel¼i¦æ¦@¦P¶D³^¤§¸q°È |
2009.8.28 |
Âù¤è¨ó°Ó¯}µõ¡ABioTechnology±NDrexel¦C¬°³Q§i |
¸ê®Æ¨Ó·½¡G¾G·ß¶W¡A¬ì§Þ¬Fµ¦¬ã¨s»P¸ê°T¤¤¤ß¡X¬ì§Þ²£·~¸ê°T«Ç¾ã²z¡A2009/09
¤T¡B¶D¤§Án©ú
- (¤@)½Ð¨Dªk°|½T»{³Q§iCiba Vision¤½¥qªº²£«~«I®`US5,080,924¡BUS5,260,093¡BUS5,326,584»PUS5,578,079µ¥¥|¥ó±M§Q¡F
- (¤G)½Ð¨Dµ¹¤©BioTechnology¦]Ciba Vision«IÅv©Ò³y¦¨ªº¹ê»Ú·l®`½ßÀv¡A¨Ã¥B©Ò±o¤§½ßÀv¤£±o¤Ö©ó¦X²zªºÅv§Qª÷¡F
- (¤T)µ¹¤©¥Ã¤[©Î¬O¼È®Éªº¸T¨î¥O¡A¸T¤îCiba Visionª½±µ«I®`¡B»²§U«I®`¥H¤Î»¤¤Þ«I®`¥ÑBioTechnology©Ò¾Ö¦³ªº¥|¥ó±M§Q¡F
- (¥|)§P¨MCiba Vision¬G·N«I®`¤Wz¥|¥ó±M§Q¡A¨Ã¥Bµ¹¤©BioTechnology·l®`ÃB«×³Ì°ª¦Ü¤T¿ªºÃg»@©Ê½ßÀvª÷¡F
- (¤) ½Ðªk°|½T»{¦¹®×¥ó¬°¬ü°ê±M§Qªk²Ä285±ø¤§¯S®í(Exceptional)±¡¨Æ¡A³Q§iÀ³µ¹¥I«ß®v¶O¤Î¶i¦æ¥»¶D³^§P¨M«e«á©Òl¥Í¥Xªº§Q®§¶O¥Î¡F
- (¤»)§P¨MDrexel¤j¾Ç¹HI·íªì©Òñq¤§¦@¦P¬ã¨s¤è®×¨óij¡F
- (¤C)§P¨MDrexel¤j¾ÇÄY«¹H¤Ï(material breach)¬ã¨s¨óij¡F
- (¤K)§P¨M¸Ó¬ã¨s¨óijµL®Ä¡A§K°£¤@¤ÁBioTechnology©ÒÀ³t¾á¤§¸q°È¡F
- (¤E)©R¥ODrexel¤j¾Ç¥²¶·¼i¦æ¸q°È»PBioTechnology¦X§@¦æ¨Ï¨tª§±M§Q¤§Åv§Q¡F
- (¤Q)µ¹¤©¥Ã¤[©Î¬O¼È®Éªº¸T¨î¥O¡G
- 1. ¸T¤î»PDrexel¤j¾Ç¦³Ãö¤§¤H¤h¡AÄ~Äò±N¤Wz±M§Q±ÂÅvµ¹¨ä¥L¤H
- 2. n¨DDrexel¤j¾ÇÂkÁÙ©Ò¦³»PBioTechnology¬ÛÃö¤§¤å¥ó(¥]§tÀÉ®×»P¬ÛÃö¹q¤lÀx¦s¨t²Î)
- (¤Q¤@)§P¨M¦]¬°Drexel¤j¾Ç¥¼¼i¦æ¦X¬ù¹ïBioTechnology©Ò³y¦¨¤§·l®`¡F
- (¤Q¤G)ªk°|»{¬°ì§i¥i¥HÀò±o¨ä¥L¤½¥¦X²zªº±ÏÀ٤覡¡C
(1385¦r¡Aªí¡G2)
ÃöÁä¦r¡G±M§Qµ¦²¤§G§½¡F±M§Q¶D³^®×¡F±M§Q«IÅv¡FBioTechnology, LLC¡FCiba Vision Corporation¡FDrexel University¡F«D¦ÛÄ@©Êì§i(Involuntary Plaintiff)¡F±MÄݳQ±ÂÅv¤H(Exclusive Licensee)¡FOphthalmic Research Corporation(ORC)¡F¦@¦P¾Ö¦³(Joint Ownership)¡F¦@¦P¬ã¨s¤è®×¨óij(Joint Research Program Agreement) ¡F²£¾Ç¦X§@
(¬ì§Þ²£·~¸ê°T«Ç--¥æ³q¤j¾Ç¬ì§Þªk«ß¬ã¨s©Ò¼B©|§Ó±Ð±Â¹Î¶¤¼¶½Z¡A2009/09/28)
|
|
|